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Obstructive sleep apnea (OSA) is a common, chronic, complex disease associated with serious cardiovascular and
neuropsychological sequelae and with substantial social and economic costs. Along with male gender, obesity is
the most characteristic feature of OSA in adults. To identify susceptibility loci for OSA, we undertook a 9-cM
genome scan in 66 white pedigrees ( subjects) ascertained on the basis of either an affected individual withnp 349
laboratory-confirmed OSA or a proband who was a neighborhood control individual. Multipoint variance-com-
ponent linkage analysis was performed for the OSA-associated quantitative phenotypes apnea-hypopnea index
(AHI) and body mass index (BMI). Candidate regions on chromosomes 1p (LOD score 1.39), 2p (LOD score
1.64), 12p (LOD score 1.43), and 19p (LOD score 1.40) gave the most evidence for linkage to AHI. BMI was also
linked to multiple regions, most significantly to markers on chromosomes 2p (LOD score 3.08), 7p (LOD score
2.53), and 12p (LOD score 3.41). Extended modeling indicated that the evidence for linkage to AHI was effectively
removed after adjustment for BMI, with the exception of the candidate regions on chromosomes 2p (adjusted LOD
score 1.33) and 19p (adjusted LOD score 1.45). After adjustment for AHI, the primary linkages to BMI remained
suggestive but were roughly halved. Our results suggest that there are both shared and unshared genetic factors
underlying susceptibility to OSA and obesity and that the interrelationship of OSA and obesity in white individuals
may be partially explained by a common causal pathway involving one or more genes regulating both AHI and
BMI levels.
Introduction
Obstructive sleep apnea (OSA [MIM 107650]) is a com-
mon disorder characterized by recurrent episodes of ap-
nea (no airflow) and hypopnea (partially obstructed air-
flow) that occur during sleep and is associated with
oxygen desaturation, sleep fragmentation, and symp-
toms of disruptive snoring and daytime sleepiness. Di-
agnosis is straightforward and is generally validated by
laboratory sleep studies (Flemons et al. 1999). The pri-
mary measure of OSA is the apnea-hypopnea index
(AHI) (Redline et al. 1991). OSA is now recognized as
a common clinical entity with serious cardiovascular and
neuropsychological sequelae and substantial social and
economic costs (Redline and Young 1993a). In the de-
veloped nations, sleep apnea is increasing in prevalence
and has been estimated to affect 2% of middle-aged
women and 4% of middle-aged men (Young et al. 1993),
1% of preschool children (Ali et al. 1993; Guillemi-
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nault and Pelayo 1998), and 11% of the elderly (An-
coli-Israel et al. 1991; Janssens et al. 2000). Annual costs
related to the diagnosis and treatment of severe OSA in
the United States are estimated to be $3 million, with
much higher costs projected for treatment of the large
number of individuals with mild-to-moderate disease
(Redline and Young 1993b).
Clinical disease likely results from multiple interact-
ing genetic and environmental factors (Redline et al.
1995), and OSA has been associated with a number of
“intermediate” pathogenic pathways, including central
obesity, craniofacial morphology, muscle and connec-
tive tissue factors, and control of ventilation (Redline
and Young 1993a). Along with male gender, obesity
(MIM 601665) is the most characteristic feature of OSA
in adults and is most commonly measured as an elevated
BMI (Strohl and Redline 1996). However, the nature of
the causal pathways involved in the relationship be-
tween BMI and AHI is uncertain (Redline and Tishler
2000).
Both nontwin family and twin studies have suggested
an important genetic component to snoring, sleeping
patterns, and OSA (Ferini-Strambi et al. 1995; Redline
et al. 1995; Heath et al. 1998; Linkowski 1999; Bux-
baum et al. 2002). The molecular genetics of OSA has
received little attention to date, and previous investi-
gations have been limited to candidate-gene association
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studies (Redline and Tishler 2000; Kadotani et al.
2001).
To identify susceptibility loci for OSA, we conducted
a genomewide scan in 66 pedigrees of European Amer-
ican origin, comprising 349 subjects. To maximize the
informativity and power of our study, families were
sampled from 1,349 white participants in the Cleveland
Family Study, a genetic-epidemiological study of OSA
(Redline et al. 1995). In these families, we have previ-
ously demonstrated increased risk of disease and ele-
vated levels of OSA-associated pathophysiological traits
among first-degree relatives of probands with OSA
(Redline et al. 1995). Since the mode of inheritance of
OSA is complex and AHI and BMI are highly corre-
lated, we conducted a multipoint model-free linkage
analysis of both AHI and BMI. A variance-component
approach appropriate for extended pedigrees was em-
ployed that utilized all of the available phenotypic and
genotypic information (Almasy and Blangero 1998).
Given the close association of obesity and OSA, we
performed linkage analysis of the AHI with and without
BMI adjustment, and vice versa.
Subjects and Methods
Families
The data analyzed are from the Cleveland Family
Study, a cohort that was assembled to study the genetic
epidemiology of OSA and was followed longitudinally.
This sample includes 179 white pedigrees; methods of
recruitment and clinical evaluation have been described
elsewhere (Redline et al. 1995). In brief, the ascertain-
ment criteria for probands with OSA was laboratory-
confirmed OSA (with either an AHI 20 or symptoms
considered severe enough to warrant therapy). During
the first 5 years of the study, control families were also
studied. Control families were identified by randomly
selecting an individual from a list provided by the pro-
bands of three neighbors who had at least two family
members residing in the metropolitan area (Redline et
al. 1995). All available first-degree relatives and selected
second-degree relatives (half-sibs, aunts, uncles, and
grandparents) of the ascertained probands with OSA or
control individuals were invited to participate. Second-
degree relatives were studied if they lived in the same
household as members of the nuclear family or if pre-
viously sampled members of the family had been found
to include two or more relatives with OSA.
Families were subselected for a whole-genome scan on
the basis of expected informativity. To enhance statistical
power, we chose only sibships with members in the ex-
tremes of the sample’s AHI distribution. Subjects were
considered to be in the high AHI extreme if they (i) were
overtly affected with OSA (lab-confirmed, requiring
treatment) or had AHIs that exceeded community age-
specific threshold levels for identifying OSA (AHI 15 for
those aged !25 years, AHI 110 for those aged 25–65
years, and AHI 115 for those aged 165 years) or (ii) had
AHIs that exceeded the sex- and age-adjusted 80th per-
centile. The lower extreme consisted of those below the
20th percentile. A sibship was chosen for genotyping if
at least two siblings were in either of the extremes and
if at least one was in the high extreme. A three-gener-
ation family was selected for genotyping if a grandparent
was in the high extreme and one or more grandchildren
were in either extreme. A total of 349 subjects in 66
pedigrees were studied in the genome-screen linkage
analysis (mean pedigree size 5.3; range 4–14).
The subjects analyzed had undergone two assessments
at an average interval of 4.05 years (SD 2.16 years). The
phenotypic data analyzed in the whole-genome scan re-
lates to the most recent survey.
Participants gave written informed consent and com-
pleted a protocol that included questionnaires, an in-
home sleep study, anthropometry, and a blood sample.
All protocols were approved by the institutional review
boards of local hospitals.
Questionnaire
Each participant aged13 years completed a modified
version of the SCOR Sleep and Health Questionnaire
(Kump et al. 1994), as described elsewhere (Redline et al.
1995); parents completed the SCOR Questionnaire for
subjects aged !13 years. Pack-years of cigarette smoking
were calculated as the product of the average number of
cigarettes smoked per day (divided by 20, to convert to
packs) and the duration of smoking (in years).
In-Home Sleep Studies (Polysomnography)
The major outcome variable was the AHI, the number
of respiratory events (either cessations [apneas] or dis-
crete discernible reductions [hypopneas] in airflow or
chest wall impedance lasting 10 s associated with a
2.5% fall in oxygen saturation) per hour of estimated
sleep time. AHI was determined using in-home, over-
night polysomnography with a portable monitor (Ed-
entec Model 1 or 2), measuring nasal/oral thermistry,
chest wall impedance, finger pulse oximetry, and heart
rate, as described elsewhere (Redline et al. 1995). This
method has been shown to yield estimates of the AHI
that have high night-to-night reproducibility and that
correlate well with values obtained using in-laboratory
polysomnography (Redline et al. 1991). Probands who
were under treatment with nasal continuous airway
pressure (CPAP) ( ; 16.8%) were assessed whennp 63
not wearing CPAP.
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Anthropometry
Height and weight were measured in stocking feet on
a flat surface, through use of a tape measure and level
and a portable scale, respectively. BMI was defined as
the weight/height2 (in kg/m2).
Genotyping and Data Management
All subjects ( ) were genotyped by the Na-np 349
tional Heart, Lung, and Blood Institute Mammalian Ge-
notyping Service (Center for Medical Genetics), using
DNA that was extracted from whole blood or buccal
scraping samples with Puregene Kits (Gentra Systems).
We analyzed 375 autosomal STR markers, with a sex-
averaged mean spacing of 9.1 cM, derived from Weber
Marker Set 10. Marker and gene locations were deter-
mined using the Human Genome Working Draft (UCSC
Genome Bioinformatics Web site) and SNPper (Univer-
sity of Arizona/Channing Labs Web site). The Kosambi
mapping function was used for all multipoint analyses.
Possible errors in our pedigree and genotype data were
assessed using the RELCHECK (Broman and Weber
1998), PEDCHECK (O’Connell and Weeks 1998), and
MERLIN (Abecasis et al. 2002) programs. The mean rate
of pedigree inconsistencies was less than one inconsistency
per marker (0.75). Marker-allele frequencies were esti-
mated, using the SOLAR program, by maximum-likeli-
hood estimation (Almasy and Blangero 1998).
Statistical Analysis
The quantitative phenotypes included in the linkage
analysis were AHI and BMI. AHI was skewed with a long
right-hand tail and was therefore loge transformed prior
to analysis. Formal tests of model fit using the FISHER
program (Lange et al. 1988) suggested that the ln (AHI)
and BMI were acceptably close to multivariate normality.
Covariate adjustments were performed within the linkage
analysis, as described below. Modeling included the in-
vestigation of polynomial and interaction terms among
covariates.
Two-point and multipoint linkage analysis of the ge-
nome-scan data was performed using a variance-com-
ponent method, as implemented in the SOLAR program
(version 1.7.4 running under Linux Mandrake version
8.0) (Almasy and Blangero 1998). SOLAR partitions the
observed phenotypic variance into additive genetic and
nongenetic components, by maximum-likelihood meth-
ods. Each model assumed that the distribution of the
response phenotype in a pedigree was multivariate nor-
mal, with a mean that depended upon a particular set
of explanatory covariates. Genotypes were imputed for
untyped individuals, conditional on all other marker
data and pedigree structure; and marker-specific iden-
tical-by-descent (IBD) matrices among all relative pairs
were estimated independently for all autosomalmarkers.
Multipoint IBD matrices were then generated at 1-cM
resolution. Expected genetic covariances among relatives
were specified as a function of the fixed effects of co-
variates, residual error, and random effects reflecting
polygenic factors and an unobserved quantitative-trait
locus (QTL) linked to an observed marker locus. The
narrow-sense heritability ( ) was defined as the ratio2hN
of variance due to additive genetic effects ( ) to the2jA
total phenotypic variance of each trait (Khoury et al.
1993): .2 2 2h p j /jN A Total
Covariates potentially modeled in the variance-com-
ponent analyses included age, age2, sex, age*sex, history
of surgery that may modify upper-airway patency (uvu-
lopalatopharyngoplasty, tonsillectomy, or nasal septal
surgery [ ; 39.5%]), self-reported alcohol con-np 138
sumption, pack-years, pack-years2, height, and height2.
In certain analyses, or BMI were modeled asln (AHI)
covariates. Covariates that were significant at P ! .05
were retained in the models.
The statistical associations between covariates entered
as fixed effects and the response variable were assessed
by removal of terms from the mean model and calcu-
lation of a likelihood-ratio x2 test statistic. The same
approach was used as an approximate guide to the “sig-
nificance” of a departure of the value of a variance com-
ponent from its null value (zero).
The null hypothesis of no linkage at a specific chro-
mosomal location was tested by comparison of a poly-
genic model to a model with genetic variance compo-
nents for both a QTL and polygenic factors. Twice the
difference in loge likelihood of these two models gives a
test statistic that is asymptotically distributed as a 1/2:
1/2 mixture of a and a point mass at zero (Self and2x1
Liang 1987). The difference between these two log10 like-
lihood values corresponds to a LOD score for linkage.
The single ascertainment scheme was corrected for in
the SOLAR program by conditioning the pedigree like-
lihood on the probability of the proband’s phenotype
for each outcome (Lange et al. 1988).
Simulations were performed using SOLAR, to assess
the statistical significance of the linkage results. Geno-
types for a fully informative unlinked marker were cre-
ated, and the evidence for linkage was assessed in
100,000 replicates. The number of times that a LOD
score exceeded a specified threshold provides an empir-
ical P value for that LOD score threshold.
Results
Demographics in Families with OSA
A total of 349 individuals were included in the ge-
nome-scan data set. The characteristics of the study pop-
ulation included in the genome-scan linkage analyses are
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Table 1
Characteristics of the Famlies Studied in the OSA Genome Scan
SAMPLE
MEAN (SD) % (NO.)
Age
(years) AHIa
Height
(cm)
Weight
(kg)
BMI
(kg/m2)
Pack-Years
of Smoking Male
Current
Smoker
Former
Smoker Nonsmoker
Probands ( )bnp 63 53.0 (11.6) 38.6 (31.9–46.6) 174.6 (8.3) 108.5 (27.2) 35.6 (9.1) 22.9 (34.4) 87.3 (55) 14.3 (9) 50.8 (32) 34.9 (22)
Parents ( )np 31 72.6 (9.2) 25.2 (19.4–32.9) 164.2 (9.6) 81.9 (17.8) 30.3 (6.0) 18.5 (25.9) 45.2 (14) 9.7 (3) 35.5 (11) 54.8 (17)
Children ( )np 89 24.8 (10.9) 5.6 (4.7–6.6) 166.8 (12.6) 79.1 (23.8) 28.0 (6.8) 1.7 (5.0) 49.4 (44) 14.6 (13) 12.4 (11) 73.0 (65)
Siblings ( )np 84 47.2 (13.1) 12.9 (10.5–15.8) 169.1 (9.0) 91.8 (24.6) 32.2 (9.6) 10.1 (15.5) 46.4 (39) 20.3 (17) 32.2 (27) 46.5 (39)
Other relatives ( )np 54 31.8 (21.8) 6.9 (5.2–9.0) 164.2 (12.9) 77.4 (32.0) 27.9 (9.1) 6.1 (12.7) 48.2 (26) 20.4 (11) 14.8 (8) 64.8 (35)
Spouses ( )np 28 53.6 (9.9) 7.2 (5.6–9.5) 164.6 (7.2) 83.5 (19.0) 30.9 (7.3) 5.1 (10.4) 14.3 (4) 7.1 (2) 32.1 (9) 60.7 (17)
a Data are geometric mean (95% CI).
b Probands with OSA. Three pedigrees studied were ascertained on the basis of probands who were community control individuals; data on these three probands
were included in the “other relatives” category of this table.
presented in table 1. The extreme values for mean AHI
and BMI in the probands are evident, as is the predom-
inance of men and ever-smokers (table 1). Consistent
with previous reports that the risk of developing OSA
increases with age in whites (Stradling 1995), parents
had higher mean AHI values than siblings, and siblings
had higher mean AHI values than children of probands.
Males and females were equally represented in the study
population as a whole (table 1). Among probands with
laboratory-diagnosed OSA, no significant differences in
mean or BMI were observed in the group thatln (AHI)
had received upper-airway surgery versus other forms of
treatment (surgery: mean  SEM ln (AHI)p 3.78
, ; nonsurgery:0.11 BMIp 34.82 1.47 ln (AHI)p
, ).3.64 0.17 BMIp 38.24 2.00
Phenotypic Modeling
Variance-component analyses using Fisher and SO-
LAR suggested that, after adjustment for all covariates,
the of the levels was 36.3% (SE 9.9%)—that2h ln (AHI)N
is, additive genetic effects ( ) contributed just over one-2jA
third of the total variance. was significantly greater2jA
than zero ( ). The variance-component mod-P ! .0001
eling suggested that sex ( ) and linear (P ! .001 P !
) and quadratic ( ) terms for age were.0000001 Pp .03
highly significant for . Levels were higher inln (AHI)
older subjects and in males. None of the other potential
covariates, including surgical treatment, were signifi-
cantly associated with the level.ln (AHI)
The of BMI was 52.8% (SE 8.8%); was signif-2 2h jN A
icantly greater than zero ( ). Linear (P ! .0000001 Pp
) and quadratic ( ) terms for age were.0004 P ! .0000001
highly significant for BMI; levels were higher in older
subjects. None of the other potential covariates, includ-
ing sex and surgical treatment, were significantly asso-
ciated with BMI.
and BMI were closely associated with eachLn(AHI)
other ( ). The of the levels after2P ! .0000001 h ln (AHI)N
inclusion of BMI as an additional covariate was reduced
to 32.8% (SE 11.1%); the of BMI after inclusion of2hN
as an additional covariate was reduced toln (AHI)
42.9% (SE 10.6%). These associations were indepen-
dent of age and sex, and the covariance model ensured
appropriate adjustment for familial correlation.
Genomewide Multipoint Variance-Component Linkage
Analysis
Genomewide multipoint variance-component linkage
results obtained using SOLAR for the and BMIln (AHI)
are presented in figures 1 and 2 and are summarized in
table 2. For , 12 multipoint LOD scores 11.0ln (AHI)
were found on 13 chromosomes. The highest LOD
scores were 1.64 on chromosome 2 (74 cM from pter,
at marker D2S1352; 2p16), 1.43 on chromosome 12 (7
cM, flanked by markers D12S372 and GATA49D12;
12p13), and 1.40 on chromosome 19 (74 cM, flanked
by markers D19S245 and D19S559; 19q13) (table 2).
After adjustment for BMI, 10 of these linkages were
greatly reduced (LOD score !0.7), suggesting that any
susceptibility loci in these regions modulating AHI act
through a pathway also involving BMI. However, the
linkages on chromosomes 2p and 19q remained essen-
tially unchanged, suggesting that these potential linkages
were to gene(s) modulating AHI largely independently
of BMI (table 2).
For BMI, 15 multipoint LOD scores 11.0 were found
on 12 chromosomes. The highest LOD scores were 3.41
on chromosome 12q (89 cM from pter, flanked by mark-
ers D12S1052 and D12S1064; 12q21), 3.08 on chro-
mosome 2p (56 cM, at marker D2S1788; 2p22), and
2.53 on chromosome 7p (5 cM, flanked by markers
D7S3056 and D7S2477; 7p22) (table 2). After adjust-
ment for , 11 of these linkages were greatly re-ln (AHI)
duced ( ), suggesting that any susceptibilityLOD ! 1.0
loci in these regions modulating BMI may also act
through a pathway involving AHI (table 2). The linkages
to BMI on chromosomes 2p, 7p, and 12q were roughly
halved after inclusion of as a covariate but re-ln (AHI)
Figure 1 Multipoint variance-component linkage analysis of all 22 autosomes in pedigrees with OSA. Linkage analysis results are presented for and BMI, with adjustment for relevantln (AHI)
covariates. The X-axis represents genetic distance (in cM) along each of the 22 autosomes, and the Y-axis represents the multipoint variance-component LOD score. Markers are arrayed in map
order along top of each plot.
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Figure 2 Multipoint variance-component linkage analysis of chromosome 2p (0–125 cM from pter). Genetic distance (in cM) is plotted
against the multipoint variance-component LOD score for , adjusted for BMI, BMI, and BMI adjusted for . Chromosomeln (AHI) ln (AHI) ln (AHI)
2 markers are arrayed in map order along the top of the plot.
mained 11 (table 2), suggesting that any susceptibility
genes in these regions may have both direct and indirect
(via a pathway involving AHI) effects on BMI.
Several broad chromosomal regions demonstrated
some evidence for linkage to both and BMI.ln (AHI)
The chromosomal region that demonstrated the most
evidence for linkage to on chromosome 2pln (AHI)
(LOD score 1.64) was also associated with strong evi-
dence for linkage to BMI (LOD score 3.08) (fig. 2). Sim-
ilarly, the chromosome 6, 9, and 11 regions that gave
some evidence of linkage to also gave someln (AHI)
evidence of linkage to BMI (table 2).
To estimate the statistical significance of the ln (AHI)
and BMI linkage results, we performed simulations with
a fully informative unlinkedmarker, followedbyvariance-
component linkage analysis of each phenotype for each
replicate. The highest observed two-point LOD scores of
particular interest in the linkage analysis wereln (AHI)
for D2S1352 (chromosome 2 at 74 cM)LODp 1.72
and for D19S246 (chromosome 19 at 78LODp 1.22
cM). In 100,000 replicates of an unlinked marker, LOD
scores1.72were observed 244 times; thus, the empirical
P value for the D2S1352 linkage to was .002.ln (AHI)
Similarly, the empirical P value for the D19S246 linkage
to was .009. The highest observed two-pointln (AHI)
LOD scores in the BMI linkage analysis were LODp
for D12S1064 (chromosome 12 at 95 cM; empirical2.68
) and at D2S1788 (chromosomePp .0002 LODp 2.42
2 at 56 cM; empirical ). Although the simu-Pp .0004
lations were based on two-point linkage analysis, it is of
interest that the multipoint LOD score for BMI on chro-
mosome 2p (3.08) was exceeded in only 8 of 100,000
simulations ( ).Pp .00008
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Table 2
Genome Scan Multipoint Linkage Analysis with SOLAR: Chromosomal Regions with LOD Scores
11.0
CHROMOSOME
LINKAGE WITH ln (AHI) LINKAGE WITH BMI
Position
(cM)
Maximum Multipoint
LOD Score
Position
(cM)
Maximum Multipoint
LOD Score
aln (AHI)
Adjustedln (AHI)
for BMIb BMIc
BMI Adjusted
for dln (AHI)
1 30 1.39 .32 … … …
2 74 1.64 1.33 56 3.08 1.64
2 … … … 149 1.72 .28
5 59 1.07 .47 14 1.81 1.08
6 190 1.16 .002 193 1.33 .02
7 112 1.29 .01 5 2.53 1.07
7 … … … 175 1.65 .71
8 … … … 124 1.02 .32
9 120 1.25 .51 113 1.39 .80
10 … … … 118 1.87 .60
11 101 1.07 .47 101 1.03 .51
12 7 1.43 .37 14 1.73 .19
12 … … … 89 3.41 1.84
14 12 1.17 .05 48 1.39 .83
17 1 1.11 .24 22 1.04 .11
19 74 1.40 1.44 36 1.21 .20
20 0 1.31 .22 … … …
a adjusted for age, age2, and sex.ln (AHI)
b adjusted for age, age2, sex, and BMI.ln (AHI)
c BMI adjusted for age and age2.
d BMI adjusted for age, age2, and .ln (AHI)
Discussion
We have conducted a whole-genome scan for OSA
through use of a sample of pedigrees selected to maxi-
mize likely informativity for linkage. Furthermore, in
recognition of the strong and consistent epidemiological
and clinical associations between obesity and OSA, we
have explored the interrelationship between the linkages
to AHI and BMI. Our genomewide linkage scan is the
first reported investigation of linkage in pedigrees with
OSA and has found evidence of linkage to several chro-
mosomal regions.
The importance of familial determinants in the reg-
ulation of BMI in humans is well established. Studies
of pedigrees and twins have suggested that BMI has a
heritability of 50%–80% (Stunkard et al. 1986; Allison
et al. 1996; Maes et al. 1997), consistent with our re-
sults. The heritability of AHI levels has not previously
received much attention, and it is of interest that our
results show strong genetic effects underlying this trait.
The majority of the observed familial correlations in
BMI and AHI were attributable to genetic rather than
environmental factors. Previous genetic studies of obe-
sity have not evaluated OSA, which may occur in as
many as 66% of obese individuals. Although obesity is
a risk factor for OSA, it is also plausible that OSA may
increase risk for obesity. For example, OSA causes sleep
fragmentation and sleepiness, effects that may promote
weight gain via reduced physical activity and hypercy-
tokinemia (Vgontzas et al. 2000). The results of the
phenotypic modeling were consistent with the hypoth-
esis that obesity and OSA have both shared and un-
shared genetic determinants. Specifically, our study
shows that the familial correlations in BMI are reduced
but remain significant after adjustment for the AHI.
Similarly, the familial correlations in AHI are reduced
but remain significant after adjustment for the BMI.
The highest observed multipoint LOD score for
was 1.64, on chromosome 2p16. This result isln (AHI)
not significant at a genomewide level but is suggestive
evidence of linkage in our data set (Lander and Krug-
lyak 1995). The 2p region also gave promising evidence
for linkage to BMI (LOD score 3.08; 2p22), corre-
sponding to significant linkage in our data set. The chro-
mosome 2p linkages may represent a pleiotropic locus
affecting both AHI and BMI independently, with ad-
ditional effects on BMI modulated through the effects
on AHI (fig. 2). Alternatively, the linkages to AHI and
BMI on chromosome 2p may represent two or more
distinct loci. Suggestive linkage to was foundln (AHI)
on chromosome 19q13. The chromosome 19q linkage
may represent the action of a locus affecting AHI in-
dependently of BMI—that is, a genetic pathway distinct
from that involved in the determination of body mass.
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Multiple genomic regions have been linked to obesity-
related phenotypes in genome-scan linkage studies (Co-
muzzie and Allison 1998); as of October 2001, 59 loci
had been linked to obesity measures in genomewide
scans of humans (Rankinen et al. 2002). Evidence for
linkage of obesity-related phenotypes to the three most
promising regions for BMI in the present study, chro-
mosomes 2p, 7p, and 12q, has been reported in previous
studies. The chromosome 2p region has been linked to
BMI, fat mass, and skinfold thickness in previous link-
age studies (Wilson et al. 1991; Bailey-Wilson et al.
1993; Comuzzie et al. 1997; Rotimi et al. 1999; Del-
planque et al. 2000). The 7p (Bray et al. 1999; Chagnon
et al. 2000) and 12q (Sun et al. 1999; Perusse et al.
2001) regions have also been previously linked to obe-
sity measures.
Several biologically plausible candidate genes are lo-
cated within the most promising chromosomal regions
in our analysis (candidate-gene locations were obtained
from the June 2002 freeze at the UCSC Genome Bioin-
formatics Web site). The chromosome 2p region con-
tains acid phosphatase 1 (MIM 171500), apolipopro-
tein B precursor (MIM 107730), proopiomelanocortin
(MIM 176830), and the alpha-2B-adrenergic receptor
(MIM 104260), all of which are biologically plausible
candidates for obesity and have been previously asso-
ciated with BMI, percentage of body fat, and/or serum
leptin levels (Rajput-Williams et al. 1988; Lucarini et
al. 1990; Saha et al. 1993; Pouliot et al. 1994; Lucarini
et al. 1997; Krude et al. 1998; Heinonen et al. 1999;
Hixson et al. 1999; Miraglia del Giudice et al. 2001).
The 7p region contains the neuropeptide Y (MIM
162640) gene, which has been associated with BMI and
waist:hip ratio (Bray et al. 2000). The 12q region con-
tains the vitamin D receptor (MIM 601769) and insulin-
like growth factor 1 (MIM 147440) genes, which have
been associated with BMI and percentage body fat (Sun
et al. 1999; Ye et al. 2001). The chromosome 19q region
contains the apolipoprotein E (MIM 107741) gene,
which regulates lipid metabolism and has been associ-
ated with serum leptin levels, measures of obesity, and
elevated AHI (Kadotani et al. 2001; Oh and Barrett-
Connor 2001; Yanagisawa et al. 2001).
Obesity appears to increase risk of OSA ∼10–14-fold,
with the most marked effects observed in middle-aged
subjects (Guilleminault et al. 1976; Strohl and Redline
1996; Redline et al. 1998). Furthermore, weight loss,
even of modest amounts, may reduce the severity of
OSA (Smith et al. 1985). Obesity may increase suscep-
tibility to OSA through fat deposition in upper-airway
tissues, reducing nasopharyngeal caliber, and/or from
hypoventilation occurring in association with reduced
chest wall compliance. It is also possible that the as-
sociation between obesity and OSAmay be partly based
on pleiotropic effects, as may occur if the same gene or
set of genes influences ponderosity and ventilatory con-
trol and/or craniofacial morphology. The co-occurrence
of OSA, central obesity, hypertension, and type 2 dia-
betes suggests that OSA may be part of a “metabolic”
syndrome (Catterrall et al. 1984; Katsumada et al.
1991; Strohl et al. 1994; Strohl 1996; Ficker et al. 1998;
Elmasry et al. 2000, 2001; Al-Delaimy et al. 2002),
which may be largely influenced by genes that influence
insulin resistance and body fat distribution (McCarthy
2002). Candidate genes for obesity are therefore rele-
vant for studies of the genetics of OSA, both because
of the prominence of obesity in the OSA phenotype and
because of the potential impact that these genes have
on the expression of other traits of potential relevance
to OSA.
There is growing evidence that leptin, an adipose-de-
rived circulating hormone, may have such pleiotropic ef-
fects (Boston 2001). In addition to the role of leptin in
appetite regulation and energy expenditure, mouse mod-
els suggest that it also influences lung growth (Tsuchiya
et al. 1999) and respiratory control (O’Donnell et al.
1999). Studies after leptin replacement in mutant obese
mice (Lepob) suggest that leptin deficiency causes de-
pressed ventilatory responses to hypercapnia in both
wakefulness and sleep (O’Donnell et al. 1999). Although
leptin-deficient mouse models have not been studied for
OSA per se, these studies provide important supporting
data implicating the pleiotropic effects that a single pro-
tein has on several aspects of theOSAphenotype (obesity,
abnormal ventilatory control, and disturbed sleep archi-
tecture) (O’Donnell et al. 1999; Sinton et al. 1999; Tsu-
chiya et al. 1999). Of great interest in this context, the
same marker giving maximal evidence of linkage to BMI
in the 2p region in our study (D2S1788) has also shown
evidence of significant linkage to leptin levels in multiple
studies (maximum LOD score 2.8–7.5) (Comuzzie et al.
1997; Hixson et al. 1999; Rotimi et al. 1999), as have
nearby markers (Hager et al. 1998; Delplanque et al.
2000). This region on chromosome 2 encompasses the
gene encoding POMC, which may be important in the
regulation of appetite, obesity, and variation in leptin
levels (Hixson et al. 1999; Miraglia del Giudice et al.
2001). Given that we found linkage to both AHI and
BMI on chromosome 2p, POMC is a biologically plau-
sible candidate that could explain the observed results
and would be consistent with a genetically regulatedmet-
abolic component to OSA pathogenesis.
In general, we observed stronger evidence of linkage
for BMI than AHI. We hypothesize that this is not due
to a larger contribution of environmental influences on
AHI than BMI, since most known environmental influ-
ences on OSA have relatively modest effects (Redline
and Young 1993a). Rather, it is likely that BMI is as-
sessed with less measurement error and greater day-to-
day consistency than is AHI, which is derived from an
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overnight recording and processing of multiple channels
of physiological data (Redline et al. 1991). Future ge-
netic studies of OSAmay benefit from ongoing advances
in the physiological processing of polysomnographic
data.
The present study has several potential limitations.
Our sample, although intensively phenotyped, was of
moderate size. Our limited power to detect modest ef-
fects may at least partially explain the modest linkages
we found to AHI. The generalizability of linkage results
in the families with OSA that we studied to OSA in
other populations with different exposures is undeter-
mined. There are well-described ethnic differences in
upper-airway anatomy that may alter the expression of
the genetic determinants of OSA among other ethnic
groups (Redline et al. 1997). We have included potential
environmental determinants of OSA, such as cigarette
smoking and alcohol consumption, as covariates in our
analyses, but we have not formally tested for genotype-
by-environment interactions. Although the quantitative
trait that we analyzed (AHI) is the most common metric
used to identify and quantify OSA, it is possible that
more sophisticated indices of overnight breathing and
sleep disruption may be more informative. Finally, we
have not adjusted for the multiple phenotypes analyzed,
because these OSA-associated quantitative phenotypes
are significantly correlated.
The present study suggests the presence of multiple
genetic determinants of the pathophysiological traits as-
sociated with OSA and suggests that two of the im-
portant phenotypes associated with OSA (AHI and
BMI) are distinct traits with both shared and unshared
genetic determinants. There are likely multiple genetic
determinants of OSA, and these linkage analyses of
quantitative phenotypes have identified several regions
of interest on which to focus fine-mapping efforts. Eval-
uation of the regions of linkage within our study
through use of additional STR markers will be required,
and replication of our findings in other samples will
be necessary. Investigation of candidate genes in the
regions of linkage will also be necessary. If novel genetic
determinants of OSA can be identified, important new
insights into OSA pathophysiology—and, ultimately,
treatment—could result.
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